260 related articles for article (PubMed ID: 28803718)
1. Total Neoadjuvant Therapy: A Shifting Paradigm in Locally Advanced Rectal Cancer Management.
Franke AJ; Parekh H; Starr JS; Tan SA; Iqbal A; George TJ
Clin Colorectal Cancer; 2018 Mar; 17(1):1-12. PubMed ID: 28803718
[TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Review of Randomized Clinical Trials Shaping the Landscape of Rectal Cancer Therapy.
Franke AJ; Skelton WP; George TJ; Iqbal A
Clin Colorectal Cancer; 2021 Mar; 20(1):1-19. PubMed ID: 32863179
[TBL] [Abstract][Full Text] [Related]
3. Locally Advanced Rectal Cancer, What is the Standard of Care?
Copur MS; Wedel W; Jonglertham P; Zusag T; Horn A
Oncology (Williston Park); 2020 Jan; 34(1):16-19. PubMed ID: 32645200
[TBL] [Abstract][Full Text] [Related]
4. Total neoadjuvant therapy for rectal cancer: An emerging option.
Ludmir EB; Palta M; Willett CG; Czito BG
Cancer; 2017 May; 123(9):1497-1506. PubMed ID: 28295220
[TBL] [Abstract][Full Text] [Related]
5. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant treatment for locally advanced rectal cancer: a systematic review.
Uehara K; Nagino M
Surg Today; 2016 Feb; 46(2):161-8. PubMed ID: 26170102
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer.
Gollins S; Sebag-Montefiore D
Clin Oncol (R Coll Radiol); 2016 Feb; 28(2):146-151. PubMed ID: 26645661
[TBL] [Abstract][Full Text] [Related]
8. Total neoadjuvant therapy for rectal cancer.
Goodman KA
Cancer Radiother; 2018 Sep; 22(5):459-465. PubMed ID: 29807808
[TBL] [Abstract][Full Text] [Related]
9. Advances and challenges in treatment of locally advanced rectal cancer.
Smith JJ; Garcia-Aguilar J
J Clin Oncol; 2015 Jun; 33(16):1797-808. PubMed ID: 25918296
[TBL] [Abstract][Full Text] [Related]
10. Capecitabine and Oxaliplatin Prior and Concurrent to Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer: Long-Term Outcome.
Hess V; Winterhalder R; von Moos R; Widmer L; Stocker P; Jermann M; Herrmann R; Koeberle D
Clin Colorectal Cancer; 2017 Sep; 16(3):240-245. PubMed ID: 27687815
[TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant chemoradiation therapy for locally advanced rectal cancer].
Sato T; Ozawa H; Kisyu K; Kumamoto H; Nakamura T; Onozato W; Yamanashi T; Kokuba Y; Ihara A; Watanabe M
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1553-6. PubMed ID: 17940371
[TBL] [Abstract][Full Text] [Related]
12. Locally advanced rectal cancer: the importance of a multidisciplinary approach.
Berardi R; Maccaroni E; Onofri A; Morgese F; Torniai M; Tiberi M; Ferrini C; Cascinu S
World J Gastroenterol; 2014 Dec; 20(46):17279-87. PubMed ID: 25516638
[TBL] [Abstract][Full Text] [Related]
13. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary Management of Locally Advanced Rectal Cancer--An Evolving Landscape?
Lee M; Gibbs P; Wong R
Clin Colorectal Cancer; 2015 Dec; 14(4):251-61. PubMed ID: 26210575
[TBL] [Abstract][Full Text] [Related]
15. [Adjuvant and perioperative neoadjuvant therapy for colorectal cancer].
Liu FQ; Cai SJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):315-320. PubMed ID: 31054544
[TBL] [Abstract][Full Text] [Related]
16. Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis.
Xu Z; Mohile SG; Tejani MA; Becerra AZ; Probst CP; Aquina CT; Hensley BJ; Arsalanizadeh R; Noyes K; Monson JR; Fleming FJ
Cancer; 2017 Jan; 123(1):52-61. PubMed ID: 27560162
[TBL] [Abstract][Full Text] [Related]
17. Role of combined-modality therapy in the management of locally advanced rectal cancer.
Hosein PJ; Rocha-Lima CM
Clin Colorectal Cancer; 2008 Nov; 7(6):369-75. PubMed ID: 19036689
[TBL] [Abstract][Full Text] [Related]
18. Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview.
Guida AM; Sensi B; Formica V; D'Angelillo RM; Roselli M; Del Vecchio Blanco G; Rossi P; Capolupo GT; Caricato M; Sica GS
Biol Direct; 2022 Jun; 17(1):16. PubMed ID: 35698084
[TBL] [Abstract][Full Text] [Related]
19. Timing of Therapies in the Multidisciplinary Treatment of Locally Advanced Rectal Cancer: Available Evidence and Implications for Routine Practice.
Sclafani F; Chau I
Semin Radiat Oncol; 2016 Jul; 26(3):176-85. PubMed ID: 27238468
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial.
Chua YJ; Barbachano Y; Cunningham D; Oates JR; Brown G; Wotherspoon A; Tait D; Massey A; Tebbutt NC; Chau I
Lancet Oncol; 2010 Mar; 11(3):241-8. PubMed ID: 20106720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
